Condition (MeSH)
Pneumonia, Mycoplasma
ClinicalTrials.gov lists 20 trials for Pneumonia, Mycoplasma or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
20 of the 20 trials are tagged with Pneumonia, Mycoplasma itself; the rest are tagged with a narrower condition beneath it.
When did Pneumonia, Mycoplasma trials start? (12)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 4
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 3 |
| 2025 | 1 |
| 2024 | 2 |
| 2022 | 1 |
| 2021 | 1 |
| 2020 | 2 |
| 2018 | 3 |
| 2016 | 2 |
| 2014 | 1 |
| 2010 | 1 |
Showing 10 of 12 earlier years.
No forecast is made for this condition: it averages 1.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Pneumonia, Mycoplasma trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 4 | 2 |
| Not applicable | 11 |
| Observational | 7 |
How many Pneumonia, Mycoplasma trials are recruiting? (5)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 3 |
| Recruiting | 1 |
| Completed | 7 |
| Terminated | 1 |
| Unknown status | 8 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Pneumonia, Mycoplasma trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| DiaSorin Molecular LLC | 1 |
| Jiangxi Qingfeng Pharmaceutical Co. Ltd. | 1 |
Which drugs are being tested for Pneumonia, Mycoplasma? (2)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| METHYLPREDNISOLONE | 2 |
| PREDNISOLONE | 1 |
Interventions as named in the registry (9)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| 1% Azithromycin | 6 |
| Doxycline | 3 |
| Azithromycin, Doxycycline, Prednisone | 1 |
| C: moxifloxacin | 1 |
| Levofloxacin 500 | 1 |
Showing 5 of 9 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Pneumonia, Mycoplasma? (53)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| The role of IFN-γ/CXCL10 axis in Mycoplasma pneumonia infection. | Scientific reports | 2025 | Yes |
| Biomarkers associated with the diagnosis and prognosis of <i>Mycoplasma pneumoniae</i> pneumonia in children: a review. | Frontiers in cellular and infection microbiology | 2025 | Yes |
| Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions. | The Lancet. Microbe | 2024 | Yes |
| A randomized controlled non-inferiority trial of placebo versus macrolide antibiotics for Mycoplasma pneumoniae infection in children with community-acquired pneumonia: trial protocol for the MYTHIC Study. | Trials | 2024 | Yes |
| Atypical pneumonia: Pathophysiology, diagnosis, and treatment. | Respiratory investigation | 2022 | Yes |
Showing 5 of 53 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.